Related Experiment Video

Updated: May 27, 2026

Analysis of Combinatorial miRNA Treatments to Regulate Cell Cycle and Angiogenesis
11:44

Analysis of Combinatorial miRNA Treatments to Regulate Cell Cycle and Angiogenesis

Published on: March 30, 2019

RNAi targeting CXCR4 inhibits tumor growth through inducing cell cycle arrest and apoptosis

Tao Yu1, Yingying Wu, Yi Huang

  • 1Department of Head and Neck Oncology Surgery, West China College of Stomatology, Sichuan University, Sichuan, People's Republic of China.

Molecular Therapy : the Journal of the American Society of Gene Therapy
|November 24, 2011
PubMed

Insights

CXC chemokine receptor 4 (CXCR4) knockdown inhibited oral squamous cell carcinoma (OSCC) growth and metastasis. This study highlights CXCR4 as a potential therapeutic target for treating aggressive oral cancers.

Area of Science:

  • Oncology
  • Molecular Biology
  • Cancer Research

Background:

  • CXC chemokine receptor 4 (CXCR4) is implicated in various human malignancies, influencing tumor progression and metastasis.
  • Understanding CXCR4's role in oral squamous cell carcinoma (OSCC) is crucial for developing targeted therapies.

Purpose of the Study:

  • To investigate the impact of CXCR4 expression on OSCC cell proliferation and metastasis.
  • To elucidate the molecular mechanisms underlying CXCR4's function in aggressive OSCC.

Main Methods:

  • Utilized Tca8113 and SCC-9 OSCC cell lines and their corresponding nude mouse xenograft models.
  • Employed RNA interference via lentiviral vectors expressing small interference RNA (siRNA) to knockdown CXCR4.
  • Analyzed alterations in gene expression related to cell cycle, apoptosis, and signaling pathways.

Main Results:

  • Knockdown of CXCR4 significantly suppressed the proliferation of highly aggressive OSCC cell lines (Tca8113 and SCC-9) both in vitro and in vivo.
  • Significant alterations were observed in the expression levels of over 1,500 genes, affecting critical cellular processes.
  • CXCR4 inhibition impacted cell cycle regulation, apoptosis induction, and multiple signaling pathways.

Conclusions:

  • CXCR4 plays a significant role in the proliferation and progression of oral squamous cell carcinoma.
  • Targeting CXCR4 through RNA interference demonstrates a promising therapeutic strategy for OSCC.
  • These findings establish CXCR4 as a potential therapeutic target for oral cancer gene therapy.

More Related Videos

A Kinetic Fluorescence-based Ca2+ Mobilization Assay to Identify G Protein-coupled Receptor Agonists, Antagonists, and Allosteric Modulators07:41

A Kinetic Fluorescence-based Ca2+ Mobilization Assay to Identify G Protein-coupled Receptor Agonists, Antagonists, and Allosteric Modulators

Published on: February 20, 2018

Through the Looking Glass: Time-lapse Microscopy and Longitudinal Tracking of Single Cells to Study Anti-cancer Therapeutics06:00

Through the Looking Glass: Time-lapse Microscopy and Longitudinal Tracking of Single Cells to Study Anti-cancer Therapeutics

Published on: May 14, 2016

Related Concept Videos

Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
Inhibition of CDK Activity02:34

Inhibition of CDK Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
Experimental RNAi02:15

Experimental RNAi

RNA interference (RNAi) is a cellular mechanism that inhibits gene expression by suppressing its transcription or activating the RNA degradation process. The mechanism was discovered by Andrew Fire and Craig Mello in 1998 in plants. Today, it is observed in almost all eukaryotes, including protozoa, flies, nematodes, insects, parasites, and mammals. This precise cellular mechanism of gene silencing has been developed into a technique that provides an efficient way to identify and determine the...
RNA Interference01:23

RNA Interference

RNA interference (RNAi) is a process in which a small non-coding RNA molecule blocks the post-transcriptional expression of a gene by binding to its messenger RNA (mRNA) and preventing the protein from being translated.
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
RNA Interference01:23

RNA Interference

RNA interference (RNAi) is a process in which a small non-coding RNA molecule blocks the post-transcriptional expression of a gene by binding to its messenger RNA (mRNA) and preventing the protein from being translated.
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
lncRNA - Long Non-coding RNAs02:39

lncRNA - Long Non-coding RNAs

In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA (lncRNA)...